Form 8-K - Current report:
SEC Accession No. 0001193125-25-159910
Filing Date
2025-07-16
Accepted
2025-07-16 16:40:09
Documents
12
Period of Report
2025-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d948992d8k.htm   iXBRL 8-K 25172
  Complete submission text file 0001193125-25-159910.txt   146622

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ikna-20250715.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20250715_lab.xml EX-101.LAB 19501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20250715_pre.xml EX-101.PRE 12169
14 EXTRACTED XBRL INSTANCE DOCUMENT d948992d8k_htm.xml XML 3909
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 251127856
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)